Sensei Biotherapeutics Ownership 2024 | Who Owns Sensei Biotherapeutics Now?
Institutional Ownership
8.41%
Insider Ownership
34.48%
Retail Ownership
57.10%
Institutional Holders
23.00
Sensei Biotherapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 2.59% | 0.07% | 650,000 | 650,000 | 100.00% | 403,065 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.47% | - | 618,757 | 44,913 | 7.83% | 383,691 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.89% | 0.00% | 223,785 | 12,785 | 6.06% | 138,769 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.69% | 0.00% | 172,835 | 172,835 | 100.00% | 107,175 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.65% | - | 163,139 | 26,821 | 19.68% | 101,180 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.31% | 0.00% | 77,900 | -35,000 | -31.00% | 48,306 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.10% | - | 25,983 | -66 | -0.25% | 16,112,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.10% | - | 25,774 | - | - | 15,982,000 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.08% | 0.00% | 19,671 | - | - | 12,198 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.07% | 0.00% | 18,600 | 18,600 | 100.00% | 11,534 | Jun 30, 2024 |
| LEO WEALTH, LLC | 0.06% | 0.00% | 14,845 | - | - | 9,205 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.00% | 14,047 | 14,047 | 100.00% | 8,711 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.06% | - | 14,000 | - | - | 8,681 | Jun 30, 2024 |
| MORGAN STANLEY | 0.05% | - | 12,219 | - | - | 7,577 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.04% | 0.01% | 11,000 | - | - | 6,821 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.04% | - | 10,000 | 10,000 | 100.00% | 5,900 | Jun 30, 2024 |
| BLACKROCK INC. | 0.03% | - | 7,777 | -25,805 | -76.84% | 4,823 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 7,087 | 374 | 5.57% | 4,394 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.02% | 0.00% | 3,900 | - | - | 2,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 748 | 80 | 11.98% | 464 | Jun 30, 2024 |
Sensei Biotherapeutics's largest institutional shareholder is IKARIAN CAPITAL, LLC, holding 2.59% of the company's total share outstanding, currently valued at $403.06K. The top 10 institutional shareholders own together 7.97% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 2.59% | 0.07% | 650,000 | 650,000 | 100.00% | 403,065 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.04% | 0.01% | 11,000 | - | - | 6,821 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.69% | 0.00% | 172,835 | 172,835 | 100.00% | 107,175 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.31% | 0.00% | 77,900 | -35,000 | -31.00% | 48,306 | Jun 30, 2024 |
| LEO WEALTH, LLC | 0.06% | 0.00% | 14,845 | - | - | 9,205 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.00% | 14,047 | 14,047 | 100.00% | 8,711 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.89% | 0.00% | 223,785 | 12,785 | 6.06% | 138,769 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.07% | 0.00% | 18,600 | 18,600 | 100.00% | 11,534 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.02% | 0.00% | 3,900 | - | - | 2,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 7,087 | 374 | 5.57% | 4,394 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.08% | 0.00% | 19,671 | - | - | 12,198 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.65% | - | 163,139 | 26,821 | 19.68% | 101,180 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.04% | - | 10,000 | 10,000 | 100.00% | 5,900 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.47% | - | 618,757 | 44,913 | 7.83% | 383,691 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.06% | - | 14,000 | - | - | 8,681 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.10% | - | 25,983 | -66 | -0.25% | 16,112,000 | Jun 30, 2024 |
| STATE STREET CORP | 0.10% | - | 25,774 | - | - | 15,982,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.05% | - | 12,219 | - | - | 7,577 | Jun 30, 2024 |
| BLACKROCK INC. | 0.03% | - | 7,777 | -25,805 | -76.84% | 4,823 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 748 | 80 | 11.98% | 464 | Jun 30, 2024 |
The largest Sensei Biotherapeutics shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 650.00K shares of Sensei Biotherapeutics (SNSE), representing 0.07% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 2.59% | 0.07% | 650,000 | 650,000 | 100.00% | 403,065 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.69% | 0.00% | 172,835 | 172,835 | 100.00% | 107,175 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.47% | - | 618,757 | 44,913 | 7.83% | 383,691 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.65% | - | 163,139 | 26,821 | 19.68% | 101,180 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.07% | 0.00% | 18,600 | 18,600 | 100.00% | 11,534 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.00% | 14,047 | 14,047 | 100.00% | 8,711 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.89% | 0.00% | 223,785 | 12,785 | 6.06% | 138,769 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.04% | - | 10,000 | 10,000 | 100.00% | 5,900 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 7,087 | 374 | 5.57% | 4,394 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 748 | 80 | 11.98% | 464 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 4 | - | - | 2 | Jun 30, 2024 |
| MORGAN STANLEY | 0.05% | - | 12,219 | - | - | 7,577 | Jun 30, 2024 |
| STATE STREET CORP | 0.10% | - | 25,774 | - | - | 15,982,000 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.06% | - | 14,000 | - | - | 8,681 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.08% | 0.00% | 19,671 | - | - | 12,198 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.02% | 0.00% | 3,900 | - | - | 2,000 | Jun 30, 2024 |
| LEO WEALTH, LLC | 0.06% | 0.00% | 14,845 | - | - | 9,205 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.04% | 0.01% | 11,000 | - | - | 6,821 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.10% | - | 25,983 | -66 | -0.25% | 16,112,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Sensei Biotherapeutics's largest institutional buyer is IKARIAN CAPITAL, LLC. The company purchased 650.00K stocks of SNSE, valued at $403.06K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEWTYN MANAGEMENT, LLC | - | - | - | -930,230 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 139 | -90,624 | -99.85% | 86 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.31% | 0.00% | 77,900 | -35,000 | -31.00% | 48,306 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -32,587 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 0.03% | - | 7,777 | -25,805 | -76.84% | 4,823 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -10,176 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -139 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.10% | - | 25,983 | -66 | -0.25% | 16,112,000 | Jun 30, 2024 |
| DEUTERIUM CAPITAL MANAGEMENT, LLC | 0.04% | 0.01% | 11,000 | - | - | 6,821 | Jun 30, 2024 |
| LEO WEALTH, LLC | 0.06% | 0.00% | 14,845 | - | - | 9,205 | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.02% | 0.00% | 3,900 | - | - | 2,000 | Jun 30, 2024 |
| CRESSET ASSET MANAGEMENT, LLC | 0.08% | 0.00% | 19,671 | - | - | 12,198 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 0.06% | - | 14,000 | - | - | 8,681 | Jun 30, 2024 |
| STATE STREET CORP | 0.10% | - | 25,774 | - | - | 15,982,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.05% | - | 12,219 | - | - | 7,577 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 4 | - | - | 2 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 748 | 80 | 11.98% | 464 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 7,087 | 374 | 5.57% | 4,394 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.04% | - | 10,000 | 10,000 | 100.00% | 5,900 | Jun 30, 2024 |
As of Jun 30 2024, Sensei Biotherapeutics's biggest institutional seller is NEWTYN MANAGEMENT, LLC. The company sold -0.93M shares of SNSE, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 2.59% | 0.07% | 650,000 | 650,000 | 100.00% | 403,065 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.69% | 0.00% | 172,835 | 172,835 | 100.00% | 107,175 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.07% | 0.00% | 18,600 | 18,600 | 100.00% | 11,534 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.06% | 0.00% | 14,047 | 14,047 | 100.00% | 8,711 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.04% | - | 10,000 | 10,000 | 100.00% | 5,900 | Jun 30, 2024 |
Sensei Biotherapeutics's largest new institutional shareholder by number of shares is IKARIAN CAPITAL, LLC, purchased 650.00K shares, valued at $403.06K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEWTYN MANAGEMENT, LLC | - | - | - | -930,230 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -32,587 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -10,176 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -139 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -133 | -100.00% | - | Jun 30, 2024 |
Sensei Biotherapeutics's largest sold out institutional shareholder by shares sold is NEWTYN MANAGEMENT, LLC, sold -0.93M shares, valued at -, as of undefined.
Sensei Biotherapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.05% | 112,900 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 19,290 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 33,652 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,114 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 36,742 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 539,482 | -97,511 | -15.31% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 43,865 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 131,923 | -635 | -0.48% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,602 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 12,075 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 15,072 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,942 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 5,968 | - | - | Jan 31, 2024 |
| JPMorgan Trust I | 0.00% | 130,900 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 500 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 11,145 | - | - | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 196 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,100 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 36,336 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,221 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 200 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 447 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 151,593 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 70,287 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 110 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 7,746 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 700 | - | - | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 22,429 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 124 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,732 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 20 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,927 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 933 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 5,638 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,584 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 29,831 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 891 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,850 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 17,600 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 144 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,304 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,932 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 400 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 10,823 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 31,307 | -824 | -2.56% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 2,275 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 570 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,919 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 7,533 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 4,064 | - | - | Mar 28, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,776 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 498 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,301 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 2,652 | - | - | Feb 29, 2024 |
Sensei Biotherapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 112.90K shares, compromising 0.05% of its total assets.
Sensei Biotherapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 23 | -4.17% |
| 31 Mar, 24 | 24 | 4.35% |
| 31 Dec, 23 | 23 | 4.55% |
| 30 Sep, 23 | 22 | -15.38% |
| 30 Jun, 23 | 26 | - |
| 31 Mar, 23 | 26 | -3.70% |
| 31 Dec, 22 | 27 | - |
| 30 Sep, 22 | 27 | -15.63% |
| 30 Jun, 22 | 32 | -20.00% |
| 31 Mar, 22 | 40 | 11.11% |
| 31 Dec, 21 | 36 | -12.20% |
| 30 Sep, 21 | 41 | 20.59% |
| 30 Jun, 21 | 34 | -15.00% |
| 31 Mar, 21 | 40 | - |
As of 30 Jun 24, 23 institutions are holding Sensei Biotherapeutics's shares, representing a decrease of -4.17% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 2,107,576 | -8.74% |
| 31 Mar, 24 | 2,309,379 | -22.04% |
| 31 Dec, 23 | 2,962,310 | -4.73% |
| 30 Sep, 23 | 3,109,261 | -1.11% |
| 30 Jun, 23 | 3,144,045 | 0.26% |
| 31 Mar, 23 | 3,135,925 | 18.74% |
| 31 Dec, 22 | 2,640,954 | -8.43% |
| 30 Sep, 22 | 2,884,036 | -7.32% |
| 30 Jun, 22 | 3,111,981 | -12.38% |
| 31 Mar, 22 | 3,551,618 | 4.29% |
| 31 Dec, 21 | 3,405,379 | -3.49% |
| 30 Sep, 21 | 3,528,677 | 51.90% |
| 30 Jun, 21 | 2,322,951 | -26.36% |
| 31 Mar, 21 | 3,154,649 | - |
Sensei Biotherapeutics (SNSE) has 2.11M shares outstanding as of 30 Jun 24, down -8.74% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 8.41% | 12.33% |
| 31 Mar, 24 | 8.26% | 6.13% |
| 31 Dec, 23 | 11.61% | 11.18% |
| 30 Sep, 23 | 10.19% | 9.82% |
| 30 Jun, 23 | 10.19% | 9.87% |
| 31 Mar, 23 | 10.16% | 13.73% |
| 31 Dec, 22 | 8.60% | 9.76% |
| 30 Sep, 22 | 9.39% | 9.14% |
| 30 Jun, 22 | 10.14% | 7.55% |
| 31 Mar, 22 | 11.59% | 7.67% |
| 31 Dec, 21 | 12.29% | 9.23% |
| 30 Sep, 21 | 11.54% | 20.00% |
| 30 Jun, 21 | 7.59% | 2.73% |
| 31 Mar, 21 | 16.69% | - |
As of 30 Jun 24, Sensei Biotherapeutics is held by 8.41% institutional shareholders, representing a 12.33% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | 66.67% |
| 31 Mar, 24 | 6 | 20.00% |
| 31 Dec, 23 | 5 | 66.67% |
| 30 Sep, 23 | 3 | -57.14% |
| 30 Jun, 23 | 7 | -22.22% |
| 31 Mar, 23 | 9 | -10.00% |
| 31 Dec, 22 | 10 | 42.86% |
| 30 Sep, 22 | 7 | -46.15% |
| 30 Jun, 22 | 13 | -31.58% |
| 31 Mar, 22 | 19 | -17.39% |
| 31 Dec, 21 | 23 | -20.69% |
| 30 Sep, 21 | 29 | 70.59% |
| 30 Jun, 21 | 17 | -57.50% |
| 31 Mar, 21 | 40 | - |
10 institutional shareholders have increased their position in SNSE stock as of 30 Jun 24 compared to 6 in the previous quarter (a 66.67% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 5 | -16.67% |
| 31 Mar, 24 | 6 | - |
| 31 Dec, 23 | 6 | - |
| 30 Sep, 23 | 6 | - |
| 30 Jun, 23 | 6 | -14.29% |
| 31 Mar, 23 | 7 | -36.36% |
| 31 Dec, 22 | 11 | -15.38% |
| 30 Sep, 22 | 13 | - |
| 30 Jun, 22 | 13 | -13.33% |
| 31 Mar, 22 | 15 | 87.50% |
| 31 Dec, 21 | 8 | -11.11% |
| 30 Sep, 21 | 9 | -30.77% |
| 30 Jun, 21 | 13 | - |
| 31 Mar, 21 | - | - |
5 institutional shareholders have reduced their position in SNSE stock as of 30 Jun 24 compared to 6 in the previous quarter (a -16.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 23 | -4.17% | 2,107,576 | -8.74% | 8.41% | 12.33% | 10 | 66.67% | 5 | -16.67% |
| 31 Mar, 24 | 24 | 4.35% | 2,309,379 | -22.04% | 8.26% | 6.13% | 6 | 20.00% | 6 | - |
| 31 Dec, 23 | 23 | 4.55% | 2,962,310 | -4.73% | 11.61% | 11.18% | 5 | 66.67% | 6 | - |
| 30 Sep, 23 | 22 | -15.38% | 3,109,261 | -1.11% | 10.19% | 9.82% | 3 | -57.14% | 6 | - |
| 30 Jun, 23 | 26 | - | 3,144,045 | 0.26% | 10.19% | 9.87% | 7 | -22.22% | 6 | -14.29% |
| 31 Mar, 23 | 26 | -3.70% | 3,135,925 | 18.74% | 10.16% | 13.73% | 9 | -10.00% | 7 | -36.36% |
| 31 Dec, 22 | 27 | - | 2,640,954 | -8.43% | 8.60% | 9.76% | 10 | 42.86% | 11 | -15.38% |
| 30 Sep, 22 | 27 | -15.63% | 2,884,036 | -7.32% | 9.39% | 9.14% | 7 | -46.15% | 13 | - |
| 30 Jun, 22 | 32 | -20.00% | 3,111,981 | -12.38% | 10.14% | 7.55% | 13 | -31.58% | 13 | -13.33% |
| 31 Mar, 22 | 40 | 11.11% | 3,551,618 | 4.29% | 11.59% | 7.67% | 19 | -17.39% | 15 | 87.50% |
| 31 Dec, 21 | 36 | -12.20% | 3,405,379 | -3.49% | 12.29% | 9.23% | 23 | -20.69% | 8 | -11.11% |
| 30 Sep, 21 | 41 | 20.59% | 3,528,677 | 51.90% | 11.54% | 20.00% | 29 | 70.59% | 9 | -30.77% |
| 30 Jun, 21 | 34 | -15.00% | 2,322,951 | -26.36% | 7.59% | 2.73% | 17 | -57.50% | 13 | - |
| 31 Mar, 21 | 40 | - | 3,154,649 | - | 16.69% | - | 40 | - | - | - |
Sensei Biotherapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Sensei Biotherapeutics's stock was made by van der Horst Edward on Feb 16 2024, selling 2,843 shares at $0.79 per share (valued at $2.25K).
Sensei Biotherapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 8 | - | - |
| Q1 2024 | 6 | 3 | 200.00% |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 19 | 2 | 950.00% |
| Q2 2023 | - | 1 | - |
| Q1 2023 | 23 | 4 | 575.00% |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 16 | - | - |
| Q1 2022 | 69 | - | - |
| Q4 2021 | 16 | - | - |
| Q3 2021 | 1 | 4 | 25.00% |
| Q2 2021 | 13 | - | - |
| Q1 2021 | 56 | 30 | 186.67% |
| Q1 2019 | - | 1 | - |
8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Sensei Biotherapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | - | 1 | - |
| Q1 2023 | 2 | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 60 | - | - |
| Q4 2021 | 16 | - | - |
| Q3 2021 | - | 4 | - |
| Q2 2021 | 12 | - | - |
| Q1 2021 | 43 | - | - |
| Q1 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Sensei Biotherapeutics's stocks.
SNSE Ownership FAQ
Who Owns Sensei Biotherapeutics?
Sensei Biotherapeutics is owned by institutional shareholders (8.41%), insiders (34.48%), and public (57.10%). The largest institutional shareholder of Sensei Biotherapeutics is IKARIAN CAPITAL, LLC (2.59% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.05% of total shares).
Who are the major institutional shareholders of Sensei Biotherapeutics?
Sensei Biotherapeutics's major institutional shareholders are IKARIAN CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BOOTHBAY FUND MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 7.30% of the company's share outstanding.
How many Sensei Biotherapeutics shareholders are there?
As of Jun 2024, there are 23 institutional shareholders of Sensei Biotherapeutics.
What percentage of Sensei Biotherapeutics is owned by IKARIAN CAPITAL, LLC?
IKARIAN CAPITAL, LLC owns 650K shares of Sensei Biotherapeutics, representing 2.59% of the company's total shares outstanding, valued at $403.06K (as of Jun 2024).
What percentage of Sensei Biotherapeutics is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 618.76K shares of Sensei Biotherapeutics (SNSE), compromising 2.47% of the company, valued at $383.69K.
What percentage of Sensei Biotherapeutics is owned by RENAISSANCE TECHNOLOGIES LLC?
RENAISSANCE TECHNOLOGIES LLC is the third largest holder of Sensei Biotherapeutics. The company owns 223.78K of the company's shares outstanding (worth $138.77K).